Sorrento Therapeutics Inc Sustainability Reports
Sorrento Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapies for cancer, autoimmune diseases, infectious diseases, and chronic pain. The company leverages its extensive proprietary fully human antibody library to engineer next-generation treatments.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300RH23PRR3M13410
FIGI: BBG001S6XW51
6 reports from 2014 to 2021